Literature DB >> 1494172

Progressive chronic pulmonary aspergillosis: a diagnostic and therapeutic challenge.

M E Ellis1, M Dossing, A al-Hokail, S H Qadri, B Hainau, J Burnie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1494172      PMCID： PMC1293772          DOI： 10.1177/014107689208501220

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  9 in total

1.  Miliary aspergillosis associated with alcoholism.

Authors:  J Blum; J C Reed; S V Pizzo; W M Thompson
Journal:  AJR Am J Roentgenol       Date:  1978-10       Impact factor: 3.959

2.  Immunoblot fingerprinting Aspergillus fumigatus.

Authors:  J P Burnie; R C Matthews; I Clark; L J Milne
Journal:  J Immunol Methods       Date:  1989-03-31       Impact factor: 2.303

3.  Immunoblot analysis of serological responses in invasive aspergillosis.

Authors:  R Matthews; J P Burnie; A Fox; S Tabaqchali
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

4.  Necrotising pulmonary aspergillosis complicating the management of patients with obstructive airways disease.

Authors:  P J George; P B Boffa; C P Naylor; T W Higenbottam
Journal:  Thorax       Date:  1983-06       Impact factor: 9.139

5.  Therapy of murine aspergillosis with amphotericin B in combination with rifampin of 5-fluorocytosine.

Authors:  J Arroyo; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

6.  Fatal Aspergillus pneumonia in chronic granulomatous disease.

Authors:  J K Kelly; A R Pinto; W A Whitelaw; O P Rorstad; T J Bowen; D S Matheson
Journal:  Am J Clin Pathol       Date:  1986-08       Impact factor: 2.493

7.  Chronic necrotising pneumonia caused by Aspergillus niger.

Authors:  J Wiggins; T J Clark; B Corrin
Journal:  Thorax       Date:  1989-05       Impact factor: 9.139

8.  Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes.

Authors:  A Schaffner; H Douglas; A Braude
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

Review 9.  Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity.

Authors:  R E Binder; L J Faling; R D Pugatch; C Mahasaen; G L Snider
Journal:  Medicine (Baltimore)       Date:  1982-03       Impact factor: 1.889
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.